Ognomy Inc. Successfully Closes Series Seed Preferred Round and Exceeds 11,000 Patients Treated

BUFFALO, NY, UNITED STATES, August 20, 2024 /EINPresswire.com/ -- Ognomy Inc., the leading telemedicine platform reshaping sleep apnea care, proudly announces the successful close of its Series Seed Preferred financing round, now having raised over $6.8MM since inception, and also marked a major milestone as the company surpassed 11,000 patients served. This pivotal round was led by Impellent Ventures, with backing from a leading strategic partner in the sleep medicine industry.